| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.6406 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.7099 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.7966 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.974 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 0.9768 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.0232 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.2808 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.347 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.5711 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | 1.7935 | Relative Abundance | CON |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|